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ABSTRACT
The synthesis and characterization of a series of hydroxamic acid namely 
benzohydroxamic acid (BHA), salicylhydroxamic acid (SHA) and their complexes 
with Cu(II), Co(II), V(IV), Zn(II), Fe(II), Ni(II) and Cr(III) are described herein. The 
characterization of the synthesized ligands and complexes were carried out by means 
of elemental analysis (C,H,N), 'H and 13C NMR and IR spectroscopy, conductivity, 
magnetic susceptibility and melting point. Through IR and NMR studies, the 
synthesized ligands were shown to possess the carbonyl (CO) and hydroxylamine 
(NH2-OH) groups, characteristics of hydroxamic acid. It was found that the dominant 
coordination mode in metal-hydroxamic acid complexes was the O, O ’-bidentate 
chelates in which the ligands were singly deprotonated (hydroxamato). The 
coordination through the carbonyl oxygen atom and the deprotonated hydroxy group 
showed a very stable five-membered chelate was formed. Moreover, depending on pH, 
two (0 ,0) bonding modes of the ligands are accessible to a series of metal ions like 
Cu(II), Cr(III), Zn(II), Fe(II) and VO(IV) where in this case, the synthesis took place 
in acidic environment which making the O, O-bonding modes were more favorable. 
The non-conductivity of the complexes as DMSO solutions indicated the absence of 
counter ions. The diamagnetic nature of the Ni(II) complex indicated that it has a 
square planar geometry whereas the paramagnetic Co(II) complex with magnetic 
moment of 4.04 B.M. indicated either high spin octahedral or tetrahedral geometry. 
Results of magnetic susceptibility studies of other complexes were also discussed 
herein in relation to their possible geometries. Cytotoxicity assay with fetal liver cells 
(WRL68) revealed the toxicity of the ligand 2,6-pyha with IC50 at 23 pM. Other 
ligands were founds to be non-toxic. Ni(II), Zn(II) and Cr(III) complexes of SHA were 
found to be non-toxic to the cells whereas V(IV), Cu(II) and Co(II) complexes 
revealed IC50 values at 25 pM, 15 pM and 60 pM, respectively. Complex VO(BHA)2 
was found to be toxic to cells with IC50 value 10 pM. Neurotoxicity testing on treated 
SHSY-5Y neuroblastoma cells showed that all ligands were found to be non-toxic to 
neuron cells at the concentration range of 1 nM to 1 mM. The complexes generally 
showed slightly increased neurotoxicity especially at higher concentration.
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